| 【Sector Research】China Property Sector – Equity financing reopens to fuel another rally |
| Q-Tech (1478 HK) – Corp Day Takeaways: Expect 4Q22E QoQ improvement; non-handset to accelerate in 2023 |
| 【Company Research】Pinduoduo (PDD US) – Strong revenue and earnings growth |
| 【Company Research】Bosideng (3998 HK) – An inline 1H9/23 result but the macro is at risk |
| 【Company Research】Meituan (3690 HK) – Long-term development intact despite short-term headwinds |
| 【Company Research】EC Healthcare (2138 HK) – Strong post-COVID business rebound |
| 【Fixed Income Research】Asian AT1s Part III – Picks on EM AT1s |
| 【Company Research】Xiaomi (1810 HK) – Weak 3Q22 as anticipated; Expect sequential recovery ahead |
| 【Company Research】CSPC Pharmaceutical (1093 HK) – Promising clinical progress of mRNA COVID-19 vaccine candidate |
| 【Company Research】Baidu (BIDU US) – Earnings beat on stringent cost control |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
